WolverHeme Happy Hour

En podcast af Bernard Marini, Anthony Perissinotti, et al.

31 Episoder

  1. Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme

    Udgivet: 21.12.2022
  2. Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

    Udgivet: 14.12.2022
  3. Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

    Udgivet: 23.11.2022
  4. Episode (3+)7: Straight Outta Roswell - OG AML Data

    Udgivet: 7.10.2022
  5. Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

    Udgivet: 21.7.2022
  6. Episode 5: IDH Inhibitors in AML: not so AGILE

    Udgivet: 3.6.2022
  7. Episode 4: All Aboard the Oncology StewardSHIP

    Udgivet: 27.5.2022
  8. Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

    Udgivet: 22.4.2022
  9. Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

    Udgivet: 22.4.2022
  10. Episode 2: We Don't Talk About Rylaze

    Udgivet: 18.3.2022
  11. Episode 1: Surrogate Endpoints in AML

    Udgivet: 11.3.2022

2 / 2

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Visit the podcast's native language site